| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/30/2014 | WO2012160223A9 Pharmaceutical composition |
| 01/30/2014 | WO2012158933A9 Macrocycllc therapeutic agents and methods of treatment |
| 01/30/2014 | WO2008019124A8 Heteroaryl compounds useful as inhibitors of e1 activating enzymes |
| 01/30/2014 | US20140031539 6-ether/thioether-purines as topoisomerase ii catalytic inhibitors and their use in therapy |
| 01/30/2014 | US20140031450 Bone treatment systems and methods |
| 01/30/2014 | US20140031435 Propofol compositions and methods for reducing pain associated with propofol injection |
| 01/30/2014 | US20140031434 Use of Patchouli Alcohol in Preparation of Drug Against Helicobacter Pylori |
| 01/30/2014 | US20140031433 Formulations of tocotrienol quinones for the treatment of ophthalmic diseases |
| 01/30/2014 | US20140031432 Treatment of mitochondrial diseases with vitamin k |
| 01/30/2014 | US20140031431 Pest-impervious packaging material and pest-control composition |
| 01/30/2014 | US20140031430 Novel antifungal composition |
| 01/30/2014 | US20140031429 Compounds for treating proliferative disorders |
| 01/30/2014 | US20140031427 Combinations of adapalene and benzoyl peroxide for treating acne lesions |
| 01/30/2014 | US20140031426 Sn-1(3) monoacylglycerides and lipid absorption |
| 01/30/2014 | US20140031422 Compositions and Methods for Treating Bruises |
| 01/30/2014 | US20140031420 Composition and method for treating diabetes and metabolic disorders |
| 01/30/2014 | US20140031419 Na/K-ATPase Ligands, Ouabain Antagonists, Assays and Uses Thereof |
| 01/30/2014 | US20140031418 Regimens and Compositions for AAV-Mediated Passive Immunization of Airborne Pathogens |
| 01/30/2014 | US20140031410 Compositions and methods for modulating angiogenesis |
| 01/30/2014 | US20140031409 Methods for treating androgen receptor dependent disorders including cancers |
| 01/30/2014 | US20140031408 Biodegradable Intravitreal Tyrosine Kinase Implants |
| 01/30/2014 | US20140031404 Cannabinoid receptor antagonists/inverse agonists useful for treating disease conditions, including metabolic disorders and cancers |
| 01/30/2014 | US20140031401 Modified Release Formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and Methods of Using the Same |
| 01/30/2014 | US20140031400 Macrocyclic compounds and methods of treatment |
| 01/30/2014 | US20140031397 Oral Dosage Form Containing A Pde 4 Inhibitor As An Active Ingredient And Polyvinylpyrrolidon As Excipient |
| 01/30/2014 | US20140031396 Oral Dosage Form Containing A Pde 4 Inhibitor As An Active Ingredient And Polyvinylpyrrolidon As Excipient |
| 01/30/2014 | US20140031393 Pyrrole compounds |
| 01/30/2014 | US20140031392 A non-retinoid rbp4 antagonist for treatment of age-related macular degeneration and stargardt disease |
| 01/30/2014 | US20140031391 Novel 5-aminotetrahydroquinoline-2-carboxylic acids and their use |
| 01/30/2014 | US20140031390 Pitavastatin-containing preparation and method for producing same |
| 01/30/2014 | US20140031389 Screening methods and pharmaceutical compositions for the treatment of inflammatory bowel diseases |
| 01/30/2014 | US20140031384 Therapeutic agent for tumor |
| 01/30/2014 | US20140031383 Methods for treatment of melanoma |
| 01/30/2014 | US20140031382 Dosage form containing oxycodone and naloxone |
| 01/30/2014 | US20140031381 Tamper resistant dosage forms |
| 01/30/2014 | US20140031380 3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists |
| 01/30/2014 | US20140031379 Camsylate Salt |
| 01/30/2014 | US20140031377 Multicomponent crystalline system of rosuvastatin calcium salt and vanillin |
| 01/30/2014 | US20140031372 Cicletanine in combination with oral antidiabetic and/or blood lipid-lowering agents as a combination therapy for diabetes and metabolic syndrome |
| 01/30/2014 | US20140031369 N-cyclopropyl-n-piperidinyl-amide derivatives, pharmaceutical compositions containing them and uses thereof |
| 01/30/2014 | US20140031367 Delta opioid receptor agonist compounds |
| 01/30/2014 | US20140031366 Azole pharmaceutical formulations for parenteral administration and methods for preparing and using the same as treatment of diseases sensitive to azole compounds |
| 01/30/2014 | US20140031364 Phenyl-isoxazol derivatives and preparation process thereof |
| 01/30/2014 | US20140031362 Tri - and tetracyclic pyrazolo[3,4-b]pyridine compounds as antineoplastic agent |
| 01/30/2014 | US20140031359 Method Of Treating Metabolic Disorders And Depression With Dopamine Receptor Agonists |
| 01/30/2014 | US20140031356 Therapy for leukemia |
| 01/30/2014 | US20140031354 Protein Kinase Inhibitors |
| 01/30/2014 | US20140031352 Solid forms of tyrosine kinase inhibitors, process for the preparation and their pharmaceutical composition thereof |
| 01/30/2014 | US20140031350 2,4-Pyrimidinediamine Compounds and Their Uses |
| 01/30/2014 | US20140031349 Inhibitors of the renal outer medullary potassium channel |
| 01/30/2014 | US20140031348 Heteroaryl sulfonamides and ccr2/ccr9 |
| 01/30/2014 | US20140031347 1,2,4-oxadiazole derivatives as drugs modulating the glp-1 peptide receptor |
| 01/30/2014 | US20140031346 5,6-dihydro-1h-pyridin-2-one compounds |
| 01/30/2014 | US20140031345 Quinazolines as potassium ion channel inhibitors |
| 01/30/2014 | US20140031343 Drug combinations containing pde4 inhibitors and nsaids |
| 01/30/2014 | US20140031341 Modulators and methods for the treatment of rosacea |
| 01/30/2014 | US20140031339 Inhibitors of leukotriene production |
| 01/30/2014 | US20140031338 Inhibitors of viral replication, their process of preparation and their therapeutical uses |
| 01/30/2014 | US20140031337 Azolotriazinone melanin concentrating hormone receptor-1 antagonists |
| 01/30/2014 | US20140031328 Gallium compounds and methods of use to treat inflammatory bowel disease |
| 01/30/2014 | US20140031326 Methods for the treatment of fibromyalgia and chronic fatigue syndrome |
| 01/30/2014 | US20140031325 Combination therapy with lenalidomide and a cdk inhibitor for treating multiple myeloma |
| 01/30/2014 | US20140031324 Compound composition for inhalation used for treating asthma |
| 01/30/2014 | US20140031323 Transdermal hormone composition and combined static-cyclic delivery |
| 01/30/2014 | US20140031322 Medicine composition containing vitamin d and metformin |
| 01/30/2014 | US20140031321 Method of inducing negative chemotaxis |
| 01/30/2014 | US20140031320 Anti-Thrombotic Compounds |
| 01/30/2014 | US20140031316 Polysaccharides comprising two antithrombin iii-binding sites, preparation thereof and use thereof as antithrombotic medicaments |
| 01/30/2014 | US20140031313 Mimicking the Metabolic Effects of Caloric Restriction by Administration of Glucose Anti-Metabolites |
| 01/30/2014 | US20140031312 Compositions and formulations of glucosamine for transdermal and transmucosal administration |
| 01/30/2014 | US20140031311 Treatment of reynaud's disease |
| 01/30/2014 | US20140031310 Pharmaceutical compositions and methods for making and using them |
| 01/30/2014 | US20140031309 Beta-L-N4 Hydroxycytosine Deoxynucleosides and their use as Pharmaceutical Agents in the Prophylaxis or Therapy of Viral Diseases |
| 01/30/2014 | US20140031306 Single dose oral formulations and methods for treatment of cats with ectoparasiticidal spinosad |
| 01/30/2014 | US20140031304 Anti-cholesterolemic compounds and methods of use |
| 01/30/2014 | US20140031303 Bioactive hybrid of ionic/polyhydroxyl, lipophilic and covalently reactive moieties and method of use |
| 01/30/2014 | US20140031301 Pharmaceutical composition, methods for treating and uses thereof |
| 01/30/2014 | US20140031299 Nutritional supplements and associated treatment methods |
| 01/30/2014 | US20140031298 Compositions and Methods for Localized Therapy of the Eye |
| 01/30/2014 | US20140031290 Novel glp-1 receptor stabilizers and modulators |
| 01/30/2014 | US20140031288 Novel composition for tumor growth control |
| 01/30/2014 | US20140031287 Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (glp-1) compound or a melanocortin-4 receptor (mic4) agonist peptide |
| 01/30/2014 | US20140031282 Formulation for treatment of hyperinsulinemic hypoglycemia following gastric bypass surgery |
| 01/30/2014 | US20140031280 Methods for preventing and treating post-traumatic stress disorder (ptsd) |
| 01/30/2014 | US20140031276 Compounds and methods for preventing or treating a viral infection |
| 01/30/2014 | US20140031275 Methods of eradicating bacterial cell populations |
| 01/30/2014 | US20140030523 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 01/30/2014 | US20140030366 Method for treating neuronal damage and neurological diseases |
| 01/30/2014 | US20140030363 Method and treatment for the reduction of atherosclerosis |
| 01/30/2014 | US20140030359 Methods and Compositions for Treating Thyroid-Related Medical Conditions with Reduced Folates |
| 01/30/2014 | US20140030356 Method for treating a pulmonary hypertension condition without companion diagnosis |
| 01/30/2014 | US20140030352 Nanodispersion |
| 01/30/2014 | US20140030350 Drug Delivery Systems |
| 01/30/2014 | US20140030343 Formulations and Methods for Attenuating Respiratory Depression Induced by Opioid Overdose |
| 01/30/2014 | US20140030340 Preparation of drug particles using evaporation precipitation into aqueous solutions |
| 01/30/2014 | US20140030337 Composition for a topical ophthalmic clear colloidal liquid which undergoes a liquid-gel phase transition in the eye |
| 01/30/2014 | US20140030336 Pharmaceutical composition for the treatment of acute disorders |
| 01/30/2014 | US20140030332 Chemosensory Receptor Ligand-Based Therapies |
| 01/30/2014 | US20140030331 Method of treating multiple sclerosis |
| 01/30/2014 | US20140030330 Dosage forms of apixaban |